|
TMEM170B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.66280000005281E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.144600E-03 |
| Normal-vs-Stage2 |
2.581600E-02 |
| Normal-vs-Stage3 |
2.71080000002755E-06 |
| Normal-vs-Stage4 |
1.70110003860913E-09 |
| Stage1-vs-Stage2 |
5.025200E-01 |
| Stage1-vs-Stage3 |
6.539900E-03 |
| Stage1-vs-Stage4 |
3.58730000000751E-05 |
| Stage2-vs-Stage3 |
4.630600E-01 |
| Stage2-vs-Stage4 |
1.535600E-01 |
| Stage3-vs-Stage4 |
2.325200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.87655999999148E-05 |
| Normal-vs-AfricanAmerican |
2.05610000025835E-07 |
| Normal-vs-Asian |
2.363400E-01 |
| Caucasian-vs-AfricanAmerican |
1.970490E-02 |
| Caucasian-vs-Asian |
7.481400E-01 |
| AfricanAmerican-vs-Asian |
1.895970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.68629999999881E-06 |
| Normal-vs-Female |
3.242500E-04 |
| Male-vs-Female |
4.648600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.56120000000182E-06 |
| Normal-vs-Age(41-60Yrs) |
4.208800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.84571999999328E-05 |
| Normal-vs-Age(81-100Yrs) |
3.535900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.138420E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.440400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.268800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.457200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.697600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.969400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.068800E-01 |
| Normal-vs-Grade 2 |
1.108020E-02 |
| Normal-vs-Grade 3 |
1.98890000002727E-06 |
| Normal-vs-Grade 4 |
3.78985731686043E-12 |
| Grade 1-vs-Grade 2 |
7.065400E-01 |
| Grade 1-vs-Grade 3 |
1.381640E-01 |
| Grade 1-vs-Grade 4 |
6.422200E-04 |
| Grade 2-vs-Grade 3 |
2.246000E-02 |
| Grade 2-vs-Grade 4 |
5.51340000320977E-08 |
| Grade 3-vs-Grade 4 |
3.364300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.052400E-02 |
| Normal-vs-ccB subtype |
1.72389999997247E-06 |
| ccA subtype-vs-ccB subtype |
4.425700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.428500E-04 |
| Normal-vs-N1 |
1.356270E-02 |
| N0-vs-N1 |
6.052200E-01 |
|
|
